NCT04453319

Brief Summary

Evaluate negative pressure wound closure therapy by PICO system in Prevention of complications of femoral artery exposure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2021

Completed
Last Updated

July 1, 2020

Status Verified

June 1, 2020

Enrollment Period

1 year

First QC Date

June 21, 2020

Last Update Submit

June 26, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Infection

    Clinical( fever, collection) and Radiological

    12 months

  • Hematoma

    Blood collected under the suture line

    12 months

  • seroma

    Fluid collected under the suture line

    12 months

Secondary Outcomes (1)

  • Wound Dehiscence

    12 Months

Study Arms (2)

Application of the device (PICO)

EXPERIMENTAL

PICO® is a disposable, single-use pump without a canister that generates an effective, non-adjustable, negative pressure of -80 mmHg and that can be used for up to 7 days.(-1113) It incorporates leak detection and low battery indicators and is connected to a 4-layer absorbent dressing that primarily removes wound exudates through evaporative loss. The mechanism of action has been postulated to occur because of the combined effects of a reduction in the frequency of dressing changes, a reduction in stress concentration in the tissue surrounding the incision, and an enhancement in the appositional strength of the incision line, thus reducing dead space and minimizing the risk of wound contamination.(14) PICO® has also been demonstrated to enhance lymphatic clearance and decrease the risk of hematomas or seromas

Procedure: Femoral Wound Closure and dressing

Conventional Dressing of the femoral wound

NO INTERVENTION

Conventional Dressing of the femoral wound

Interventions

Femoral Wound Closure and dressing

Application of the device (PICO)

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All femoral artery exposure whatever the type of surgery

You may not qualify if:

  • who can't give consent (unconscious)
  • Those with mental or behavioral disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura

Al Mansurah, Mansoura University, 35111, Egypt

RECRUITING

Related Publications (1)

  • Correia RM, Nakano LC, Vasconcelos V, Cristino MA, Flumignan RL. Prevention of infection in peripheral arterial reconstruction of the lower limb. Cochrane Database Syst Rev. 2025 Oct 29;10(10):CD015022. doi: 10.1002/14651858.CD015022.pub2.

MeSH Terms

Conditions

Wound InfectionSurgical Wound

Interventions

Bandages

Condition Hierarchy (Ancestors)

InfectionsWounds and Injuries

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Central Study Contacts

Mosaad A Soliman, P.h.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Block randomization
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized Comparative study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2020

First Posted

July 1, 2020

Study Start

January 31, 2020

Primary Completion

January 30, 2021

Study Completion

January 30, 2021

Last Updated

July 1, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations